CNC
Centene Corp. · Healthcare · Medical - Healthcare Plans
Momentum inputs (comparable managers):
holder breadth +12.5% ·
share flow -0.6% ·
net new positions +11.1%
— formula
Ownership fragmentation — more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 169 | +2 | 380.11M | $24.37B | +5 | −2 |
| Q1 2026 | 169 | +4 | 362.48M | $11.86B | +7 | −4 |
| Q4 2025 | 164 | -1 | 388.17M | $15.98B | +2 | −2 |
| Q3 2025 | 26 | +2 | 229.56M | $8.20B | +3 | −2 |
| Q2 2025 | 22 | 0 | 267.14M | $14.49B | +2 | −2 |
| Q1 2025 | 19 | -1 | 141.75M | $8.61B | — | −1 |
| Q4 2024 | 20 | +1 | 155.02M | $9.39B | +2 | −1 |
| Q3 2024 | 18 | +2 | 123.00M | $9.25B | +3 | −1 |
| Q2 2024 | 16 | — | 123.78M | $8.20B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Harris Associates (Oakmark) ✦ | 26.31M | +5.7% | $1.98B | 3.3% | ▲ Add | 2 | SEC ↗ ×2 |
| 2 | Norges Bank ✦ (passive) | 22.97M | +8.3% | $1.73B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 3 | Capital World Investors ✦ | 22.57M | -15.3% | $1.70B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 17.33M | -9.1% | $1.30B | 0.2% | ▼ Trim | 2 | SEC ↗ ×8 |
| 5 | Geode Capital Management ✦ (passive) | 12.66M | -0.2% | $950.05M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 6 | Arrowstreet Capital ✦ | 7.15M | -11.1% | $538.25M | 0.5% | ▼ Trim | 2 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 5.42M | +21.5% | $403.24M | 0.6% | ▲ Add | 2 | SEC ↗ ×5 |
| 8 | Millennium Management ✦ | 2.01M | +218.7% | $151.68M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 1.97M | -26.3% | $148.16M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 10 | Citadel Advisors ✦ | 1.65M | +209.0% | $124.27M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 11 | Renaissance Technologies ✦ | 729.01K | New | $54.88M | 0.1% | New | 1 | SEC ↗ |
| 12 | Marshall Wace ✦ | 510.59K | +304.3% | $38.44M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 13 | Adage Capital Partners ✦ | 483.81K | +5.9% | $36.42M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 467.25K | +5.2% | $35.17M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 262.16K | -20.2% | $19.74M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 16 | Point72 Asset Management ✦ | 248.00K | New | $18.67M | 0.1% | New | 1 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 137.20K | -15.1% | $10.33M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 118.93K | New | $8.95M | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $54.88M | 0.1% |
| Point72 Asset Management | $18.67M | 0.1% |
| Two Sigma Investments | $8.95M | 0.0% |
Exited
| Glenview Capital | $94.90M | was 2.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 856 holders, 470.26M shares, $14.63B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 56.50K sh · $3.78M
Officer · 47.60K sh · $3.11M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology